Mark A. Feitelson, of the Biology Department at the College of Science and Technology, received a grant from the National Institutes of Health for the project, “Combination Therapies for Chronic HBV, Liver Disease and Cancer.” The award provides $336,600 for the first year of support, with total funding estimated at $1,783,000 for the period June 15, 2008 through May 31, 2013.